Solothurn – The W.A. de Vigier Foundation crowns this year’s prize winners. Six young companies win the award, which is endowed with 120,000 Swiss francs. These are CellX Biosolutions, Visienco, New Roots, PAVE Space, Axmed and Clee Medical.
(CONNECT) The Solothurn-based W.A. de Vigier Foundation is presenting the award of the same name for young companies for the 36th time. This year, six companies will receive the prize, which is endowed with 120,000 Swiss francs, according to a press release. Four further finalists will be awarded 20,000 Swiss francs.
“We were very impressed by the quality of the top 10. The differences between the finalists are often minimal - in the end, it is often the personalities behind the projects that make the difference,” said Hanna Byland, CEO of the W.A. de Vigier Foundation, in the press release. “Their commitment to responsible entrepreneurship strengthens our confidence that they will successfully implement their ideas.”
This year's winners include CellX Biosolutions AG with CEO Estelle Clerc from Zurich, which offers bacteria-based solutions to purify chemical waste from toxic substances such as PFAS, pesticides and pharmaceutical residues and convert them into safe substances. Visienco AG, led by CEO Edwige Guinet and based at Technopark Lucerne in Root, has been recognized for its drug research supported by artificial intelligence, in which tests are carried out on organoids, mini-organs grown in the laboratory. The tests are intended to accelerate drug research at low cost and reduce the need for animal testing. New Roots AG from Oberdiessbach BE, managed by CEO Freddy Hunziker, offers an alternative to environmentally harmful cow's milk, a protein-rich lupin milk that can be processed in cheese dairies with lower CO2 emissions and water consumption.
PAVE Space SA from Chavannes-près-Renens VD is honored with CEO Julie Böhning for a project that aims to extend the service life of space satellites by refueling and maintaining them on site. A prototype is to be launched in 2027. With its medical portal, Basel-based Axmed AG aims to give underprivileged groups around the world access to medical care. As a B2B company, Axmed around CEO Emmanuel Akpakwu also acts as an intermediary between manufacturers, retailers and non-governmental organizations. And CEO Matthew Lapinski and Clee Medical SA from Geneva received the award for their approach to making brain surgery more precise and with reduced risk for patients with the support of artificial intelligence and machine learning. ce/ww
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information